AB-FUB2201 is a promising cannabinoid synthetic with great research potential. This comprehensive guide will provide you with all the information that you need about AB FUB 2201 including its chemical properties, development, effects and dosage.
Development and Background
AB-FUB2201, a synthetic cannabinoid, is part of the AB Series. It’s also called the FUBINACA Series. While it is not known who developed AB FUB2201, the compound has attracted considerable attention from researchers because of its unique pharmacological characteristics and structural similarity to other synthetic cannabinoids such as AB FUBINACA and AB CHMINACA.
CAS Number and Chemical name
AB-FUB2201 has the CAS number 242500-21-5. This is used as a unique identifier in scientific databases. The IUPAC (International Union of Pure and Applied Chemistry) name for AB-FUB2201 is N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-5-(4-fluorophenyl)-3H-imidazole-4-carboxamide. This name provides researchers with a standard reference and describes the chemical structure of the compound.
Molecular Formula
The molecular formula of AB-FUB2201 is C26H29F2N5O. This means that it contains 26 Carbon atoms and 29 Hydrogen atoms. It also contains two Fluorine atoms. Its molecular mass is 463.54g/mol.
Shape and color of the compound
AB-FUB2201 is typically a powdery white or off-white color. Its crystalline structure makes it easy to work with and handle during research. Store AB-FUB2201 away from heat, direct sunlight, and in a dry, cool place to maintain its integrity.
Uses and effects of AB FUB 2201
AB-FUB2201 is not approved for human consumption, nor medical use. However, it has been used in scientific research as a potent agonist of the CB1 cannabinoid receptors. These receptors are essential in many physiological processes such as the regulation of pain, immune system function and mood regulation. Researchers are studying AB-FUB2201 in order to better understand both the endocannabinoid and synthetic cannabinoids.
AB-FUB2201 has a high affinity and selectivity towards the CB1 CB1 receptor which is primarily found in the brain. The compound mimics the effects of cannabinoids such as THC. These effects can include feelings of euphoria and relaxation, altered perceptions, and an increased appetite. Due to its potency, AB FUB 2201 can cause more intense side effects.
Dosage and precautions
AB-FUB2201, a research chemical that has not been approved by the FDA for human consumption is to be handled with extreme caution. Researchers who work with AB-FUB2201 must adhere to strict safety protocol, including wearing personal protective equipment.
In vitro and in vivo, the dose of ABFUB2201 must be determined carefully based on study objectives and conditions. When designing experiments, researchers must also consider the compound’s potency as well as its potential for adverse effects.
Reviews
There are no reviews yet.